Canada
Should Investors Buy the Dip in Canopy Growth Stock?
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
Canopy Growth's Latest Results Can Be Wrapped Up in One Word: Ugly
The cannabis company's performance as outlined in its year-end report should not inspire investor confidence.
Canopy Growth Slips as Production, Margins Disappoint
While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.
A Deeply Undervalued Dividend Stock From the North
With its high dividend yield, Manulife investors are paid well to be patient.
A Top Stock for Income Investors After Huge Earnings Beat
This Canadian energy name has paid dividends for over 64 years to its shareholders.
Canopy Growth Is Ready for an Upside Move: When to Go Long
Let's visit with the charts and indicators to see how things are shaping up today.
Cannabis Firm Cresco Labs Skips the Flash, Keeps It Real
With over 56 brands, CRLBF has something for everyone and that is the secret sauce of this unassuming company.
Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
Japan Holds the Advantage as U.S. Begs for Trade Talks
President Trump's decision to pull out of the Trans-Pacific Partnership has left the U.S. in a weaker trade position with Japan and other partnership members.
2 Huge Earnings Reports I'm Watching This Week
A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.